Cary Street Partners Investment Advisory’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$192K Sell
684
-15
-2% -$3.94K 0.04% 385
2026
Q1
$187K Buy
699
+31
+5% +$8.39K 0.05% 361
2025
Q4
$168K Buy
668
+47
+8% +$12.5K 0.05% 357
2025
Q3
$178K Buy
621
+57
+10% +$15.3K 0.07% 286
2025
Q2
$148K Buy
564
+21
+4% +$5.11K 0.07% 280
2025
Q1
$126K Buy
543
+78
+17% +$18.9K 0.07% 273
2024
Q4
$107K Sell
465
-16,625
-97% -$3.81M 0.07% 256
2024
Q3
$3.82M Buy
17,090
+44
+0.3% +$9.67K 0.14% 168
2024
Q2
$3.47M Buy
17,046
+573
+3% +$117K 0.14% 168
2024
Q1
$3.6M Buy
16,473
+140
+0.9% +$30.8K 0.15% 159
2023
Q4
$3.71M Buy
16,333
+293
+2% +$61.5K 0.18% 153
2023
Q3
$3.22M Sell
16,040
-2,028
-11% -$428K 0.17% 155
2023
Q2
$3.75M Sell
18,068
-88
-0.5% -$17.1K 0.24% 118
2023
Q1
$3.58M Hold
18,156
0.26% 98
2022
Q4
$3.67M Hold
18,156
0.27% 95
2022
Q3
$3.19M Buy
18,156
+957
+6% +$196K 0.26% 97
2022
Q2
$3.46M Buy
17,199
+1,018
+6% +$217K 0.29% 89
2022
Q1
$3.67M Sell
16,181
-35
-0.2% -$8.23K 1.01% 19
2021
Q4
$4.38M Buy
16,216
+35
+0.2% +$8.66K 1.21% 18
2021
Q3
$3.91M Sell
16,181
-511
-3% -$129K 1.28% 16
2021
Q2
$3.96M Buy
16,692
+6,463
+63% +$1.47M 1.28% 15
2021
Q1
$2.24M Sell
10,229
-945
-8% -$190K 0.92% 25
2020
Q4
$1.95M Sell
11,174
-1,412
-11% -$244K 0.38% 65
2020
Q3
$2.04M Buy
+12,586
New +$1.99M 0.43% 69

Other funds holding LH

Cary Street Partners Investment Advisory's LH Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Labcorp (LH) stake by 2.1% in Q2 2026, selling an estimated $3.94K and leaving 684 shares worth $192K. The position accounts for 0.04% of the portfolio, ranked #385.

Cary Street Partners Investment Advisory first reported a position in LH in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.38M in Q4 2021. 560 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Cary Street Partners Investment Advisory held 684 shares of Labcorp worth $192K as of Q2 2026.
  • Cary Street Partners Investment Advisory sold 15 Labcorp shares in Q2 2026, an estimated $3.94K.
  • Labcorp made up 0.04% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #385 holding.
  • Cary Street Partners Investment Advisory first reported a position in Labcorp in Q3 2020 and has held it in 24 quarters since.
  • Cary Street Partners Investment Advisory's Labcorp position peaked at $4.38M in Q4 2021.
  • 560 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.